Streptococcal cysteine protease augments lung injury induced by products of group A streptococci

Infection and Immunity

Volumn 64, Issue 3, 1996, Pages 870-877

  Shanley, Thomas P ^a   Schrier, Dennis ^b   Kapur, Vivek ^d   Kehoe, Michael ^c   Musser, James M ^d   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Department of Immunopathology ^*  (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL ENZYME; CYSTEINE PROTEINASE; CYTOKINE; INTERLEUKIN 1BETA; NITRIC OXIDE; STREPTOLYSIN O; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BLOOD VESSEL PERMEABILITY; ENZYME ACTIVITY; HEMOLYSIS; IMMUNOREACTIVITY; LUNG BLOOD VESSEL; LUNG INJURY; LUNG LAVAGE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME;

EID: 0030042784     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.3.870-877.1996     Document Type: Article

References (35)

1. Beutler, B. 1989. Cachcctin in tissue injury, shock and related states. Crit. Care Clin 5:353-367
2. Bhakdi, S., M. Roth, A. Sziegoleit, and J. Tranum-Jensen. 1984 Isolation and identification of two hemolytic forms of streptolysin-O. Infect. Immun 46:394-400.
3. Bjorck, L., P. Akesson, M. Bohus, J. Trojnar, M. Abrahamson, I. Olafsson, and A. Grubb. 1989. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature (London) 337:385-386.
4. Cone, L. A., D. R. Woodard, P. M. Schlievert, and G. S. Tomory. 1987. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N. Engl. J. Med. 317:146-149.
5. DeVuono, J., and C. Panos. 1978. Effect of L-form Streptococcus pyogenes and of lipoteichoic acid on human cells in tissue culture. Infect. Immun. 22:255-265.
6. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99-105.
7. Ginsburg, I., D. F. Gibbs, L. Schuger, K. J. Johnson, U. S. Ryan, P. A. Ward, and J. Varani. 1989. Vascular endothelial cell killing by combinations of membrane-active agents and hydrogen peroxide. Free Radical Biol. Med 7:369-376.
8. Ginsburg, I., and R. Kohen. 1995. Synergistic effects among oxidants, membrane-damaging agents, fatty acids, proteinases and xenobiotics: killing of epithelial cells and release of arachidonic acid. Inflammation 19:101-118.
9. Ginsburg, I., R. Misgav, A. Pinson, J. Varani, P. A. Ward, and R. Kohen. 1992. Synergism among oxidants, proteinases, phospholipases, microbial hemolysins, cationic proteins, and cytokines: a possible major cause of cell and tissue destruction in inflammation (a working hypothesis) Inflammation 16:519-537.
10. Hackett, S., and D. L. Stevens. 1992. Streptococcal toxic shock syndrome synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J. Infect. Dis. 165:879-885.
11. Hoge, C. W., B. Schwartz, D. F. Talkington, R. F. Breiman, E. M. MacNeill, and S. J. Englender. 1993. The challenging epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 269:384-389.
12. Holm, S. E., A. Norrby, A.-M. Bergholm, and M. Norgren. 1992. Aspects of pathogenesis of serious group A streptococcal infections in Sweden. J. Infect. Dis. 166:31-37
13. Hyers, T. M., S. M. Tricomi, P. A. Dettenmeier, and A. A. Fowler. 1991. Tumor necrosis factor levels m serum and bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am. Rev Respir Dis 144:268-271.
14. Jones, S. P. 1994. California counties investigate five cluckenpox-related deaths. Infect Dis Child 7(5):20, 37.
15. Kapur, V., J. T. Maffei, R. S. Greer, L.-L. Li, G. J. Adams, and J. M. Musser. 1994. Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci. Microb. Pathog. 16:443-450.
16. Kapur, V., M. W. Majesky, L.-L. Li, R. A. Black, and J. M. Musser. 1993. Cleavage of interleukin 1β (IL-1β) precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 90:7676-7680.
17. Kapur, V., S. Topouzis, M. W. Majesky, L.-L. Li, M. R. Hamrick, R. J. Hamill, J. M. Patti, and J. M. Musser. 1993. A conserved Streptococcus pyogenes extracellular protease cleaves human fibronectin and degrades vitronectin Microb. Pathog. 15:327-346.
18. Leon, O., and C. Panos. 1983. Cytotoxicity and inhibition of normal collagen synthesis in mouse fibroblasts by lipoteichoic acid from Streptococcus pyogenes type 12. Infect Immun. 40:785-794.
19. Mattsson, E., J. Rollof, J. Verhoef, H. Van Dijk, and A. Fleer. 1994. Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan involvement of different serum factors. Infect. Immun 62:3837-3843.
20. Mulligan, M. S., J. M. Hevel, M. A. Marietta, and P. A. Ward. 1991. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl. Acad. Sci. USA 88:6338-6342.
21. Musser, J. M. 1992 Clinical relevance of streptococcal pyrogenic exotoxins in streptococcal toxic shock-like syndrome and other severe invasive infections. Ped. Ann. 21:821-828.
22. Musser, J. M., A. R. Hauser, M. Kim, P. M. Schlievert, K. Nelson, and R. K. Selander. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression Proc Natl. Acad. Sci. USA 88:2668-2672
23. Schirmer, W. J., J. M. Schirmer, and D. E. Fry. 1989. Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch. Surg 124:445-448.
24. Suter, P. M., S. Suter, E. Girardin, P. Roux-Lombard, G. E. Grau, and J.-M. Dayer. 1991 High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon and elastase. in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev. Respir. Dis. 145:1016-1022
25. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, J. D. Albert, G. T. Shires, and A. Cerami. 1986 Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
26. Tracey, K. J., S. F. Lowry, and A. Cerami. 1988. Cachectin/TNF-alpha in septic shock and septic adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:1377-1379.
27. Tran Van Nhieu, J., B. Misset, F. Lebargy, J. Carlet, and J. F. Bernaudin. 1993. Expression of tumor necrosis factor-alpha gene in alveolar macrophages from patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147:1585-1589.
28. Ulich, T. R., K. Guo, S. Yin, J. del Castillo, E. S. Yi, R. C. Thompson, and S. P. Eisenberg. 1992. Endotoxin-induced cytokine gene expression in vivo. Am. J. Pathol 141:61-68
29. Ulich, T. R., L. R. Watson, S. Yin, K. Guo, P. Wang, H. Thang, and J. del Castillo. 1991 The intratracheal administration of endotoxin and cytokines Am J Pathol. 138:1485-1496.
30. Walmrath, D., H. A. Ghofrani, S. Rosseau, H. Schutte, A. Cramer, W. Kaddus, F. Grimminger, S. Bhakdi, and W. Seeger. 1994. Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin, an example of synergism between endo-and exotoxin. J Exp Med. 180:1437-1443.
31. Ward, P. A., and M. S. Mulligan. 1993. Molecular mechanisms in acute lung injury. Adv. Pharmacol. 24:275-292.
32. Warner, R. L., R. Paine, P. J. Christensen, M. A. Marietta, M. K. Richards, S. E. Wilcoxen, and P. A. Ward. 1995 Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am. J. Respir. Cell Mol Biol. 12:649-661.
33. Werner-Felmayer, G., E. R. Werner, D. Fuchs, A. Hansen, G. Reibnegger, and H. Wachter. 1990. Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J. Exp Med. 172:1599-1607.
34. Yu, C.-E., and J. J. Ferretti. 1989. Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains Infect. Immun. 57:3715-3719.
35. Yu, C.-E., and J. J. Ferretti. 1991 Frequency of the erythrogenic toxin B and C genes (speB and speC) among clinical isolates of group A streptococci. Infect Immun 59:211-215.